These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36836325)

  • 1. Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses.
    Perez L; Corne P; Pasquier G; Konecki C; Sadek M; Le Bihan C; Klouche K; Mathieu O; Reynes J; Cazaubon Y
    J Fungi (Basel); 2023 Feb; 9(2):. PubMed ID: 36836325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Wu X; Venkataramanan R; Rivosecchi RM; Tang C; Marini RV; Shields RK; Clancy CJ; Nguyen MH
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints.
    Kovanda LL; Petraitiene R; Petraitis V; Walsh TJ; Desai A; Bonate P; Hope WW
    J Antimicrob Chemother; 2016 Jul; 71(7):1885-91. PubMed ID: 27084921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isavuconazole for COVID-19-Associated Invasive Mold Infections.
    Ullah N; Sepulcri C; Mikulska M
    J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against
    Cojutti PG; Carnelutti A; Lazzarotto D; Sozio E; Candoni A; Fanin R; Tascini C; Pea F
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi.
    Desai A; Kovanda L; Kowalski D; Lu Q; Townsend R; Bonate PL
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5483-91. PubMed ID: 27381396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations.
    Zurl C; Waller M; Schwameis F; Muhr T; Bauer N; Zollner-Schwetz I; Valentin T; Meinitzer A; Ullrich E; Wunsch S; Hoenigl M; Grinschgl Y; Prattes J; Oulhaj A; Krause R
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32580296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis.
    Höhl R; Bertram R; Kinzig M; Haarmeyer GS; Baumgärtel M; Geise A; Muschner D; Prosch D; Reger M; Naumann HT; Ficker JH; Kubitz J; Steinmann J; Sörgel F
    Mycoses; 2022 Jul; 65(7):747-752. PubMed ID: 35535740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19.
    Bertram R; Naumann HT; Bartsch V; Hitzl W; Kinzig M; Haarmeyer GS; Baumgärtel M; Geise A; Muschner D; Nentwich J; John S; Sörgel F; Steinmann J; Höhl R
    Mycoses; 2023 Dec; 66(12):1071-1078. PubMed ID: 37700457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?
    Cazaubon Y; Talineau Y; Feliu C; Konecki C; Russello J; Mathieu O; Djerada Z
    Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31683663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol: A randomized, double-blind, placebo-controlled trial of isavuconazole prophylaxis for the prevention of covid-19-associated pulmonary aspergillosis.
    Jenks JD; Hoenigl M; Thompson GR
    Contemp Clin Trials Commun; 2024 Jun; 39():101310. PubMed ID: 38832095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review.
    Mertens B; Elkayal O; Dreesen E; Wauters J; Meersseman P; Debaveye Y; Degezelle K; Vermeersch P; Gijsen M; Spriet I
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
    Miller M; Kludjian G; Mohrien K; Morita K
    Am J Health Syst Pharm; 2022 Jul; 79(15):1245-1249. PubMed ID: 35377411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring.
    Bolcato L; Thiebaut-Bertrand A; Stanke-Labesque F; Gautier-Veyret E
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder.
    Jin ZB; Wu Z; Cui YF; Liu XP; Liang HB; You JY; Wang CY
    Front Pharmacol; 2022; 13():913935. PubMed ID: 35860024
    [No Abstract]   [Full Text] [Related]  

  • 19. Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies.
    Jansen AME; Mertens B; Spriet I; Verweij PE; Schouten J; Wauters J; Debaveye Y; Ter Heine R; Brüggemann RJM
    Clin Pharmacokinet; 2023 Dec; 62(12):1701-1711. PubMed ID: 37819503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isavuconazole Therapeutic Drug Monitoring during Long-Term Treatment for Chronic Pulmonary Aspergillosis.
    Kosmidis C; Otu A; Moore CB; Richardson MD; Rautemaa-Richardson R
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.